About Us

About Purely Grow

Purely Grow Inc is a startup company founded in June, 2022. The Company runs within the scope of the biotech industry. From 3D tissue culture to AI analysis, the company is developing human-relevant 3D tissue platforms and AI-driven architectural analysis tools to improve translational accuracy in drug development and precision oncology. By combining its native collagen fiber scaffold technology, ColFi3D™, with FibroAI™, an artificial intelligence platform that quantifies tissue-level structural response, the company enables more physiologically meaningful drug testing and therapeutic evaluation. Purely Grow’s mission is to bridge the gap between laboratory models and patient outcomes by rebuilding tissue architecture in vitro and transforming complex biological data into actionable insight for clinicians, researchers, and pharmaceutical partners.